Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Intestinal microbiota and vaccine efficacy in children from resource poor settings â potential impact for the usefulness of probiotics?
in Beneficial MicrobesSearch for other papers by N. Hajela in
Current site
Google Scholar
Search for other papers by S. Chattopadhyay in
Current site
Google Scholar
Search for other papers by G.B. Nair in
Current site
Google Scholar
Search for other papers by N.K. Ganguly in
Current site
Google Scholar
Developing countries continue to contribute significantly to the global burden of childhood mortality due to infectious diseases. Infections leading to diseases like diarrhoea, pneumonia and meningitis account for millions of deaths annually. Most of these diseases are preventable by vaccination and therefore global vaccination rates have risen substantially with clear benefits. But paradoxically, the vaccines have demonstrated lower immunogenicity in developing countries as compared to their industrialised counterparts. Malnutrition in resource poor settings along with repeated polymicrobial infections at early age are some of the reasons for the differences in vaccine efficacy in different settings. Recent studies indicate that the gastrointestinal microbiota possibly influences maturation of immune system as well as vaccine efficacy. In this review we discuss evidences from in vitro, animal and human studies showing that probiotics can positively modulate gut microbiota composition and exert immunomodulatory effects on the host. We also discuss how they should be evaluated for their ability to improve vaccine performance especially in low resource settings.
Kauf
Sofortzugang erwerben (PDF-Download und unbegrenzter Online-Zugang):
Institutszugang
Melden Sie sich mit Open Athens, Shibboleth oder Ihren institutionellen Anmeldedaten an.
Persönliche Anmeldung
Melden Sie sich mit Ihrem brill.com-Konto an
-
Bar-Zeev, N., King, C., Phiri, T., Beard, J., Mvula, H., Crampin, A.C., Heinsbroek, E., Lewycka, S., Tate, J.E. and Parashar, U.D., 2018. Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study. The Lancet Global Health 6: e1036-e1044.
'Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study ' () 6 The Lancet Global Health : e1036 -e1044.
-
Belkaid, Y. and Hand, T.W., 2014. Role of the microbiota in immunity and inflammation. Cell 157: 121-141. https://doi.org/10.1016/j.cell.2014.03.011
-
Bermudez-Brito, M., Plaza-Diaz, J., Munoz-Quezada, S., Gomez-Llorente, C. and Gil, A., 2012. Probiotic mechanisms of action. Annals of Nutrition and Metabolism 61: 160-174. https://doi.org/10.1159/000342079
-
Boge, T., Remigy, M., Vaudaine, S., Tanguy, J., Bourdet-Sicard, R. and Van der Werf, S., 2009. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27: 5677-5684. https://doi.org/10.1016/j.vaccine.2009.06.094
-
Bosch, M., Méndez, M., Pérez, M., Farran, A., Fuentes, M. and Cuñé, J., 2012. Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly. Nutrición Hospitalaria 27: 504-509. https://doi.org/10.1590/S0212-16112012000200023
-
Bunout, D., Barrera, G., Hirsch, S., Gattas, V., De la Maza, M.P., Haschke, F., Steenhout, P., Klassen, P., Hager, C., Avendano, M., Petermann, M. and Munoz, C., 2004. Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. Journal of Parenteral and Enteral Nutrition 28: 348-354. https://doi.org/10.1177/0148607104028005348
-
Cano-Garrido, O., Seras-Franzoso, J. and Garcia-Fruitos, E., 2015. Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes. Microbial Cell Factories 14: 137. https://doi.org/10.1186/s12934-015-0313-6
-
Carding, S., Verbeke, K., Vipond, D.T., Corfe, B.M. and Owen, L.J., 2015. Dysbiosis of the gut microbiota in disease. Microbial Ecology in Health and Disease 26: 26191.
'Dysbiosis of the gut microbiota in disease ' () 26 Microbial Ecology in Health and Disease : 26191.
-
Cong, Y., McArthur, M.A., Cohen, M., Jahrling, P.B., Janosko, K.B., Josleyn, N., Kang, K., Zhang, T. and Holbrook, M.R., 2016. Characterization of yellow fever virus infection of human and non-human primate antigen presenting cells and their interaction with CD4+ T cells. PLoS Neglected Tropical Diseases 10: e0004709. https://doi.org/10.1371/journal.pntd.0004709
-
Cryz Jr, S.J., Levine, M.M., Kaper, J.B., Furer, E. and Althaus, B., 1990. Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults. Vaccine 8: 577-580.
'Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults ' () 8 Vaccine : 577 -580.
-
Cunliffe, N., Kirsten, M., Madhi, S., Witte, D., Ngwira, B. and Pieter Bos, C., 2009. Efficacy of human rotavirus vaccine RIX4414 in Africa during the first year of life. Pediatric Infectious Disease Journal 28: 524.
'Efficacy of human rotavirus vaccine RIX4414 in Africa during the first year of life ' () 28 Pediatric Infectious Disease Journal : 524.
-
Davidson, L.E., Fiorino, A.M., Snydman, D.R. and Hibberd, P.L., 2011. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. European Journal of Clinical Nutrition 65: 501-507. https://doi.org/10.1038/ejcn.2010.289
-
De Vrese, M., Rautenberg, P., Laue, C., Koopmans, M., Herremans, T. and Schrezenmeir, J., 2005. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. European Journal of Nutrition 44: 406-413. https://doi.org/10.1007/s00394-004-0541-8
-
Dong, H., Rowland, I., Tuohy, K.M., Thomas, L.V. and Yaqoob, P., 2010. Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production. Clinical and Experimental Immunology 161: 378-388. https://doi.org/10.1111/j.1365-2249.2010.04173.x
-
Fang, H., Elina, T., Heikki, A. and Seppo, S., 2000. Modulation of humoral immune response through probiotic intake. FEMS Immunology and Medical Microbiology 29: 47-52. https://doi.org/10.1111/j.1574-695X.2000.tb01504.x
-
Fernandez, M.I., Pedron, T., Tournebize, R., Olivo-Marin, J.C., Sansonetti, P.J. and Phalipon, A., 2003. Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells. Immunity 18: 739-749.
'Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells ' () 18 Immunity : 739 -749.
-
Food and Agriculture Organisation/World Health Organisation (FAO/WHO), 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Joint FAO/WHO Expert Consultation, Cordoba, Argentina.
-
Ghadimi, D., Hassan, M., Njeru, P.N., De Vrese, M., Geis, A., Shalabi, S.I., Abdel-Razek, S.T., Abdel-Khair Ael, A., Heller, K.J. and Schrezenmeir, J., 2011. Suppression subtractive hybridization identifies bacterial genomic regions that are possibly involved in hBD-2 regulation by enterocytes. Molecular Nutrition and Food Research 55: 1533-1542. https://doi.org/10.1002/mnfr.201100052
-
Gilmartin, A.A. and Petri Jr, W.A., 2015. Exploring the role of environmental enteropathy in malnutrition, infant development and oral vaccine response. Philosophical Transactions of the Royal Society B 370(1671). https://doi.org/10.1098/rstb.2014.0143
-
Goncalves, P., Araujo, J.R. and Di Santo, J.P., 2018. A cross-talk between microbiota-derived short-chain fatty acids and the host mucosal immune system regulates intestinal homeostasis and inflammatory bowel disease. Inflammatory Bowel Disease 24: 558-572. https://doi.org/10.1093/ibd/izx029
-
Green, R.J. and Kolberg, J.M., 2016. Neonatal pneumonia in sub-Saharan Africa. Pneumonia 8: 3.
'Neonatal pneumonia in sub-Saharan Africa ' () 8 Pneumonia : 3.
-
Greenwood, B., Salisbury, D. and Hill, A.V., 2011. Vaccines and global health. Philosophical Transactions of the Royal Society B 366(1579): 2733-2742.
'Vaccines and global health ' () 366 Philosophical Transactions of the Royal Society B : 2733 -2742.
-
Grigg, J.B. and Sonnenberg, G.F., 2017. Host-microbiota interactions shape local and systemic inflammatory diseases. Journal of Immunology 198: 564-571. https://doi.org/10.4049/jimmunol.1601621
-
Groer, M.W., Luciano, A.A., Dishaw, L.J., Ashmeade, T.L., Miller, E. and Gilbert, J.A., 2014. Development of the preterm infant gut microbiome: a research priority. Microbiome 2: 38.
'Development of the preterm infant gut microbiome: a research priority ' () 2 Microbiome : 38.
-
Hallander, H.O., Paniagua, M., Espinoza, F., Askelof, P., Corrales, E., Ringman, M. and Storsaeter, J., 2002. Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children. Vaccine 21: 138-145. https://doi.org/10.1016/s0264-410x(02)00348-1
-
Hardy, H., Harris, J., Lyon, E., Beal, J. and Foey, A.D., 2013. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 5: 1869-1912. https://doi.org/10.3390/nu5061869
-
Hughes, S. and Kelly, P., 2006. Interactions of malnutrition and immune impairment, with specific reference to immunity against parasites. Parasite Immunology 28: 577.
'Interactions of malnutrition and immune impairment, with specific reference to immunity against parasites ' () 28 Parasite Immunology : 577.
-
International Monetary Fund, 2019. World economic outlook database, October 2018. Available at: https://www.imf.org/external/pubs/ft/weo/2018/02/weodata/index.aspx.
-
Ivanov, II, Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K.C., Santee, C.A., Lynch, S.V., Tanoue, T., Imaoka, A., Itoh, K., Takeda, K., Umesaki, Y., Honda, K. and Littman, D.R., 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485-498. https://doi.org/10.1016/j.cell.2009.09.033
-
Kukkonen, K., Nieminen, T., Poussa, T., Savilahti, E. and Kuitunen, M., 2006. Effect of probiotics on vaccine antibody responses in infancy â a randomized placebo-controlled double-blind trial. Pediatric Allergy & Immunology 17: 416-421. https://doi.org/10.1111/j.1399-3038.2006.00420.x
-
Lagos, R., Fasano, A., Wasserman, S.S., Prado, V., San Martin, O., Abrego, P., Losonsky, G.A., Alegria, S. and Levine, M.M., 1999. Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR. Journal of Infectious Diseases 180: 1709-1712. https://doi.org/10.1086/315051
-
Lei, W.T., Shih, P.C., Liu, S.J., Lin, C.Y. and Yeh, T.L., 2017. Effect of probiotics and prebiotics on immune response to influenza vaccination in adults: a systematic review and meta-analysis of randomized controlled trials. Nutrients 9: E1175. https://doi.org/10.3390/nu9111175
-
Lemon, K.P., Armitage, G.C., Relman, D.A. and Fischbach, M.A., 2012. Microbiota-targeted therapies: an ecological perspective. Science Translational Medicine 4: 137rv135. https://doi.org/10.1126/scitranslmed.3004183
-
Levine, M.M., 2010. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biology 8: 129.
'Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine ' () 8 BMC Biology : 129.
-
Licciardi, P.V., Ismail, I.H., Balloch, A., Mui, M., Hoe, E., Lamb, K. and Tang, M.L., 2013. Maternal supplementation with LGG reduces vaccine-specific immune responses in infants at high-risk of developing allergic disease. Frontiers in Immunology 4: 381. https://doi.org/10.3389/fimmu.2013.00381
-
Lievin-Le Moal, V. and Servin, A.L., 2014. Anti-infective activities of Lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clinical Microbiology Reviews 27: 167-199. https://doi.org/10.1128/CMR.00080-13
-
Lin, A., Bik, E.M., Costello, E.K., Dethlefsen, L., Haque, R., Relman, D.A. and Singh, U., 2013. Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS ONE 8: e53838. https://doi.org/10.1371/journal.pone.0053838
-
Linhares, A.C., Velázquez, F.R., Pérez-Schael, I., Sáez-Llorens, X., Abate, H., Espinoza, F., López, P., MacÃas-Parra, M., Ortega-BarrÃa, E. and Rivera-Medina, D.M., 2008. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. The Lancet 371: 1181-1189.
'Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study ' () 371 The Lancet : 1181 -1189.
-
Link-Amster, H., Rochat, F., Saudan, K.Y., Mignot, O. and Aeschlimann, J.M., 1994. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunology and Medical Microbiology 10: 55-63. https://doi.org/10.1111/j.1574-695X.1994.tb00011.x
-
Llewellyn, A. and Foey, A., 2017. Probiotic modulation of innate cell pathogen sensing and signaling events. Nutrients 9: E1156. https://doi.org/10.3390/nu9101156
-
Ludwig, I.S., Broere, F., Manurung, S., Lambers, T.T., Van der Zee, R. and Van Eden, W., 2018. Lactobacillus rhamnosus GG-derived soluble mediators modulate adaptive immune cells. Frontiers in Immunology 9: 1546. https://doi.org/10.3389/fimmu.2018.01546
-
Maidens, C., Childs, C., Przemska, A., Dayel, I.B. and Yaqoob, P., 2013. Modulation of vaccine response by concomitant probiotic administration. British Journal of Clinical Pharmacology 75: 663-670. https://doi.org/10.1111/j.1365-2125.2012.04404.x
-
Matsuda, F., Chowdhury, M. I., Saha, A., Asahara, T., Nomoto, K., Tarique, A. A., Ahmed, T., Nishibuchi, M., Cravioto, A. and Qadri, F., 2011. Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: A randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age. Vaccine 29: 1855-1858. https://doi.org/10.1016/j.vaccine.2010.12.133
-
Mazmanian, S.K. and Lee, Y.K., 2014. Interplay between intestinal microbiota and host immune system. Journal of Bacteriology and Virology 44(1): 1-9. https://dx.doi.org/10.4167/jbv.2014.44.1.1
-
Million, M., Diallo, A. and Raoult, D., 2017. Gut microbiota and malnutrition. Microbial Pathogenesis 106: 127-138. https://doi.org/10.1016/j.micpath.2016.02.003
-
Monira, S., Nakamura, S., Gotoh, K., Izutsu, K., Watanabe, H., Alam, N.H., Endtz, H.P., Cravioto, A., Ali, S.I., Nakaya, T., Horii, T., Iida, T. and Alam, M., 2011. Gut microbiota of healthy and malnourished children in Bangladesh. Frontiers in Microbiology 2: 228. https://doi.org/10.3389/fmicb.2011.00228
-
Nakaya, H.I. and Bruna-Romero, O., 2015. Is the gut microbiome key to modulating vaccine efficacy? Expert Review of Vaccines 14: 777-779. https://doi.org/10.1586/14760584.2015.1040395
-
Okayasu, H., Sutter, R.W., Czerkinsky, C. and Ogra, P.L., 2011. Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission. Vaccine 29: 8205-8214.
'Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission ' () 29 Vaccine : 8205 -8214.
-
Olivares, M., DÃaz-Ropero, M.P., Sierra, S., Lara-Villoslada, F., Fonollá, J., Navas, M., RodrÃguez, J.M. and Xaus, J., 2007. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23: 254-260. https://doi.org/10.1016/j.nut.2007.01.004
-
Oria, R.B., Murray-Kolb, L.E., Scharf, R.J., Pendergast, L.L., Lang, D.R., Kolling, G.L. and Guerrant, R.L., 2016. Early-life enteric infections: relation between chronic systemic inflammation and poor cognition in children. Nutrition Reviews 74: 374-386. https://doi.org/10.1093/nutrit/nuw008
-
Parker, E.P., Ramani, S., Lopman, B.A., Church, J.A., Iturriza-Gomara, M., Prendergast, A.J. and Grassly, N.C., 2018. Causes of impaired oral vaccine efficacy in developing countries. Future Microbiology 13: 97-118.
'Causes of impaired oral vaccine efficacy in developing countries ' () 13 Future Microbiology : 97 -118.
-
Patel, M., Pedreira, C., De Oliveira, L.H., Tate, J., Orozco, M., Mercado, J., Gonzalez, A., Malespin, O., Amador, J.J. and Umaña, J., 2009a. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. Jama 301: 2243-2251.
'Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua ' () 301 Jama : 2243 -2251.
-
Patel, M., Shane, A.L., Parashar, U.D., Jiang, B., Gentsch, J.R. and Glass, R.I., 2009b. Oral rotavirus vaccines: how well will they work where they are needed most? Journal of Infectious Diseases 200: S39-S48.
'Oral rotavirus vaccines: how well will they work where they are needed most? ' () 200 Journal of Infectious Diseases : S39 -S48.
-
Phillips, D.E., Dieleman, J.L., Lim, S.S. and Shearer, J., 2017. Determinants of effective vaccine coverage in low and middle-income countries: a systematic review and interpretive synthesis. BMC Health Services Research 17: 681.
'Determinants of effective vaccine coverage in low and middle-income countries: a systematic review and interpretive synthesis ' () 17 BMC Health Services Research : 681.
-
Prescott, S.L., Wickens, K., Westcott, L., Jung, W., Currie, H., Black, P.N., Stanley, T.V., Mitchell, E.A., Fitzharris, P., Siebers, R., Wu, L. and Crane, J., 2008. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clinical and Experimental Allergy 38: 1606-1614. https://doi.org/10.1111/j.1365-2222.2008.03061.x
-
Rizzardini, G., Eskesen, D., Calder, P.C., Capetti, A., Jespersen, L. and Clerici, M., 2012. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition 107: 876-884. https://doi.org/10.1017/S000711451100420X
-
Rytter, M.J.H., Kolte, L., Briend, A., Friis, H. and Christensen, V.B., 2014. The immune system in children with malnutrition â a systematic review. PLoS ONE 9: e105017.
'The immune system in children with malnutrition â a systematic review ' () 9 PLoS ONE : e105017.
-
Serazin, A.C., Shackelton, L.A., Wilson, C. and Bhan, M.K., 2010. Improving the performance of enteric vaccines in the developing world. Nature Publishing Group, London, UK.
'Improving the performance of enteric vaccines in the developing world', ().
-
Seria Masole Shonyela, G.W., Yang, W., Yang, G. and Wang, C.F., 2017. New progress regarding the use of lactic acid bacteria as live delivery vectors, treatment of diseases and induction of immune responses in different host species focusing on Lactobacillus species. Journal of Probiotics and Health 5: 187.
'New progress regarding the use of lactic acid bacteria as live delivery vectors, treatment of diseases and induction of immune responses in different host species focusing on Lactobacillus species ' () 5 Journal of Probiotics and Health : 187.
-
Soh, S.E., Ong, D.Q., Gerez, I., Zhang, X., Chollate, P., Shek, L.P., Lee, B.W. and Aw, M., 2010. Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant hepatitis B vaccination. Vaccine 28: 2577-2579. https://doi.org/10.1016/j.vaccine.2010.01.020
-
Suharyono, Simanjuntak, C., Witham, N., Punjabi, N., Heppner, D.G., Losonsky, G., Totosudirjo, H., Rifai, A.R., Clemens, J. and Lim, Y.L., 1992. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. The Lancet 340: 689-694.
'Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children ' () 340 The Lancet : 689 -694.
-
Takahashi, K., Orito, N., Tokunoh, N. and Inoue, N., 2019. Current issues regarding the application of recombinant lactic acid bacteria to mucosal vaccine carriers. Applied Microbiology and Biotechnology 103: 5947-5955. https://doi.org/10.1007/s00253-019-09912-x
-
Taylor, A.L., Hale, J., Wiltschut, J., Lehmann, H., Dunstan, J.A. and Prescott, S.L., 2006. Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses. Clinical and Experimental Allergy 36: 1227-1235. https://doi.org/10.1111/j.1365-2222.2006.02553.x
-
Tourneur, E. and Chassin, C., 2013. Neonatal immune adaptation of the gut and its role during infections. Clinical and Developmental Immunology 2013: 270301. https://doi.org/10.1155/2013/270301
-
Tricarico, S., McNeil, H.C., Cleary, D.W., Head, M.G., Lim, V., Yap, I.K.S., Wie, C.C., Tan, C.S., Norazmi, M.N. and Aziah, I., 2017. Pneumococcal conjugate vaccine implementation in middle-income countries. Pneumonia 9: 6.
'Pneumococcal conjugate vaccine implementation in middle-income countries ' () 9 Pneumonia : 6.
-
Velly, H., Britton, R.A. and Preidis, G.A., 2017. Mechanisms of cross-talk between the diet, the intestinal microbiome, and the undernourished host. Gut Microbes 8: 98-112. https://doi.org/10.1080/19490976.2016.1267888
-
Vilander, A.C. and Dean, G.A., 2019. Adjuvant strategies for lactic acid bacterial mucosal vaccines. Vaccines 7: E150. https://doi.org/10.3390/vaccines7040150
-
Vitetta, L., Saltzman, E., Thomsen, M., Nikov, T. and Hall, S., 2017. Adjuvant probiotics and the intestinal microbiome: enhancing vaccines and immunotherapy outcomes. Vaccines 5: 50.
'Adjuvant probiotics and the intestinal microbiome: enhancing vaccines and immunotherapy outcomes ' () 5 Vaccines : 50.
-
Vlasova, A.N., Chattha, K.S., Kandasamy, S., Liu, Z., Esseili, M., Shao, L., Rajashekara, G. and Saif, L.J., 2013. Lactobacilli and bifidobacteria promote immune homeostasis by modulating innate immune responses to human rotavirus in neonatal gnotobiotic pigs. PLoS ONE 8: e76962. https://doi.org/10.1371/journal.pone.0076962
-
Wells, J., 2011. Mucosal vaccination and therapy with genetically modified lactic acid bacteria. Annual Review of Food Science and Technology 2: 423-445. https://doi.org/10.1146/annurev-food-022510-133640
-
Wen, K., Li, G., Bui, T., Liu, F., Li, Y., Kocher, J., Lin, L., Yang, X. and Yuan, L., 2012. High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. Vaccine 30: 1198-1207. https://doi.org/10.1016/j.vaccine.2011.11.107
-
West, C.E., Gothefors, L., Granstrom, M., Kayhty, H., Hammarstrom, M.L. and Hernell, O., 2008. Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. Pediatric Allergy and Immunology 19: 53-60. https://doi.org/10.1111/j.1399-3038.2007.00583.x
-
Whitney, C.G., Farley, M.M., Hadler, J., Harrison, L.H., Bennett, N.M., Lynfield, R., Reingold, A., Cieslak, P.R., Pilishvili, T. and Jackson, D., 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. New England Journal of Medicine 348: 1737-1746.
'Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine ' () 348 New England Journal of Medicine : 1737 -1746.
-
Winkler, P., Ghadimi, D., Schrezenmeir, J. and Kraehenbuhl, J.P., 2007. Molecular and cellular basis of microflora-host interactions. Journal of Nutrition 137: 756S-772S. https://doi.org/10.1093/jn/137.3.756S
-
World Bank, 2015. Child mortality rates plunge by more than half since 1990 but global mdg target missed by wide margin. World Bank, Washington, DC, USA. Press release, 8 September 2015. Available at: https://tinyurl.com/yb3ermro
-
World Health Organization (WHO), 2009. Meeting of the immunization strategic advisory group of experts, April 2009 â conclusions and recommendations. Weekly Epidemiological Record 84: 220-236.
-
Wyszynska, A., Kobierecka, P., Bardowski, J. and Jagusztyn-Krynicka, E.K., 2015. Lactic acid bacteria â 20 years exploring their potential as live vectors for mucosal vaccination. Applied Microbiology and Biotechnology 99: 2967-2977. https://doi.org/10.1007/s00253-015-6498-0
-
Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R.N., Anokhin, A.P., Heath, A.C., Warner, B., Reeder, J., Kuczynski, J., Caporaso, J.G., Lozupone, C.A., Lauber, C., Clemente, J.C., Knights, D., Knight, R. and Gordon, J.I., 2012. Human gut microbiome viewed across age and geography. Nature 486: 222-227. https://doi.org/10.1038/nature11053
-
Yeh, T.L., Shih, P.C., Liu, S.J., Lin, C.H., Liu, J.M., Lei, W.T. and Lin, C.Y., 2018. The influence of prebiotic or probiotic supplementation on antibody titers after influenza vaccination: a systematic review and meta-analysis of randomized controlled trials. Drug Design, Development and Therapy 12: 217-230. https://doi.org/10.2147/DDDT.S155110
-
Yilmaz, B., Portugal, S., Tran, T.M., Gozzelino, R., Ramos, S., Gomes, J., Regalado, A., Cowan, P.J., dâApice, A.J., Chong, A.S., Doumbo, O.K., Traore, B., Crompton, P.D., Silveira, H. and Soares, M.P., 2014. Gut microbiota elicits a protective immune response against malaria transmission. Cell 159: 1277-1289. https://doi.org/10.1016/j.cell.2014.10.053
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 524 | 171 | 28 |
| Gesamttextansichten | 11 | 2 | 0 |
| PDF-Downloads | 16 | 1 | 0 |
Intestinal microbiota and vaccine efficacy in children from resource poor settings â potential impact for the usefulness of probiotics?
in Beneficial MicrobesSearch for other papers by N. Hajela in
Current site
Google Scholar
PubMed
Search for other papers by S. Chattopadhyay in
Current site
Google Scholar
PubMed
Search for other papers by G.B. Nair in
Current site
Google Scholar
PubMed
Search for other papers by N.K. Ganguly in
Current site
Google Scholar
PubMed
Developing countries continue to contribute significantly to the global burden of childhood mortality due to infectious diseases. Infections leading to diseases like diarrhoea, pneumonia and meningitis account for millions of deaths annually. Most of these diseases are preventable by vaccination and therefore global vaccination rates have risen substantially with clear benefits. But paradoxically, the vaccines have demonstrated lower immunogenicity in developing countries as compared to their industrialised counterparts. Malnutrition in resource poor settings along with repeated polymicrobial infections at early age are some of the reasons for the differences in vaccine efficacy in different settings. Recent studies indicate that the gastrointestinal microbiota possibly influences maturation of immune system as well as vaccine efficacy. In this review we discuss evidences from in vitro, animal and human studies showing that probiotics can positively modulate gut microbiota composition and exert immunomodulatory effects on the host. We also discuss how they should be evaluated for their ability to improve vaccine performance especially in low resource settings.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 524 | 171 | 28 |
| Gesamttextansichten | 11 | 2 | 0 |
| PDF-Downloads | 16 | 1 | 0 |
